- Home
- PEPG vs BOWN Comparison
PEPG vs BOWN Comparison
Compare PEPG & BOWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- BOWN
- Stock Information
- Founded
- PEPG 2018
- BOWN 2023
- Country
- PEPG United States
- BOWN United States
- Employees
- PEPG N/A
- BOWN N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- BOWN
- Sector
- PEPG Health Care
- BOWN
- Exchange
- PEPG Nasdaq
- BOWN Nasdaq
- Market Cap
- PEPG 52.4M
- BOWN N/A
- IPO Year
- PEPG 2022
- BOWN 2023
- Fundamental
- Price
- PEPG $1.54
- BOWN $10.70
- Analyst Decision
- PEPG Buy
- BOWN
- Analyst Count
- PEPG 3
- BOWN 0
- Target Price
- PEPG $9.67
- BOWN N/A
- AVG Volume (30 Days)
- PEPG 224.8K
- BOWN 46.1K
- Earning Date
- PEPG 05-08-2025
- BOWN 01-01-0001
- Dividend Yield
- PEPG N/A
- BOWN N/A
- EPS Growth
- PEPG N/A
- BOWN N/A
- EPS
- PEPG N/A
- BOWN 0.32
- Revenue
- PEPG N/A
- BOWN N/A
- Revenue This Year
- PEPG N/A
- BOWN N/A
- Revenue Next Year
- PEPG N/A
- BOWN N/A
- P/E Ratio
- PEPG N/A
- BOWN $38.26
- Revenue Growth
- PEPG N/A
- BOWN N/A
- 52 Week Low
- PEPG $0.88
- BOWN $2.71
- 52 Week High
- PEPG $19.30
- BOWN $19.77
- Technical
- Relative Strength Index (RSI)
- PEPG 52.07
- BOWN 51.89
- Support Level
- PEPG $1.33
- BOWN $11.30
- Resistance Level
- PEPG $1.66
- BOWN $12.71
- Average True Range (ATR)
- PEPG 0.17
- BOWN 1.01
- MACD
- PEPG 0.01
- BOWN -0.15
- Stochastic Oscillator
- PEPG 76.47
- BOWN 44.17
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.